OLAPARIB vs OLOPATADINE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
OLAPARIB vs OLOPATADINE: Safety Overview
| Metric | OLAPARIB | OLOPATADINE |
|---|---|---|
| Total FAERS Reports | 18,274 | 8,787 |
| Deaths Reported | 5,496 | 89 |
| Death Rate | 30.1% | 1.0% |
| Hospitalizations | 3,471 | 171 |
| Average Patient Age | 62.3 yrs | 56.7 yrs |
| % Female Patients | 79.9% | 73.2% |
| FDA Approval Date | Aug 17, 2017 | Apr 15, 2008 |
| Manufacturer | AstraZeneca Pharmaceuticals LP | Alcon Laboratories, Inc. |
| Route | ORAL | OPHTHALMIC |
| Marketing Status | Discontinued | OTC |